RBOT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RBOT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Vicarious Surgical's average Accounts Payable for the three months ended in Dec. 2022 was $3.33 Mil. Vicarious Surgical's Cost of Goods Sold for the three months ended in Dec. 2022 was $0.00 Mil.
The historical rank and industry rank for Vicarious Surgical's Days Payable or its related term are showing as below:
Vicarious Surgical's Days Payable stayed the same from Dec. 2021 (0.00) to Dec. 2022 (0.00). stayed the same
The historical data trend for Vicarious Surgical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicarious Surgical Annual Data | ||||
Trend | Dec20 | Dec21 | Dec22 | |
Days Payable | - | - | - |
For the Medical Devices subindustry, Vicarious Surgical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Vicarious Surgical's Days Payable distribution charts can be found below:
* The bar in red indicates where Vicarious Surgical's Days Payable falls in comparison to its industry or sector. The grey bar indicates the Days Payable's extreme value range as defined by GuruFocus.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Vicarious Surgical's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as
Days Payable (A: Dec. 2022 ) | |||||||||
= | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Accounts Payable (A: Dec. 2021 ) | + | Accounts Payable (A: Dec. 2022 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2022 ) | * | Days in Period |
= | ( (1.5 | + | 1.731) | / | 2 ) | / | 0 | * | 365 |
= | 1.6155 | / | 0 | * | 365 | ||||
= | N/A |
Vicarious Surgical's Days Payable for the quarter that ended in Dec. 2022 is calculated as:
Days Payable (Q: Dec. 2022 ) | |||||||||
= | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Accounts Payable (Q: Sep. 2022 ) | + | Accounts Payable (Q: Dec. 2022 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2022 ) | * | Days in Period |
= | ( (4.933 | + | 1.731) | / | 2 ) | / | 0 | * | 365 / 4 |
= | 3.332 | / | 0 | * | 365 / 4 | ||||
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Vicarious Surgical's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.
Beverly A Huss | director | C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089 |
Chelvey International Ltd | 10 percent owner | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
June Morris | officer: CLO, General Counsel and Sec | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
David Michael Styka | director | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Philip Liang | director | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Dror Berman | director, 10 percent owner | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Sammy Khalifa | director, 10 percent owner, officer: Chief Technology Officer | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Innovation Endeavors Iii Lp | 10 percent owner | 10 EAST 53RD STREET, 14TH FLOOR, NEW YORK NY 10022 |
Ric Fulop | director | C/O DESKTOP METAL, INC., 63 THIRD AVENUE, BURLINGTON MA 01803 |
Khosla Ventures Seed Associates C, Llc | 10 percent owner | 2128 SAND HILL ROAD, MENLO PARK CA 94025 |
Khosla Ventures Seed C, L.p. | 10 percent owner | 2128 SAND HILL ROAD, MENLO PARK CA 94025 |
Khosla Ventures V, L.p. | 10 percent owner | 2128 SAND HILL ROAD, MENLO PARK CA 94025 |
Khosla Ventures Associates V, Llc | 10 percent owner | 2128 SAND HILL ROAD, MENLO PARK CA 94025 |
William John Kelly | officer: CFO and Treasurer | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
Barry Stuart Greene | 10 percent owner | C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451 |
From GuruFocus
By Business Wire 06-08-2022
By Business Wire 06-21-2022
By Business Wire 11-10-2022
By Business Wire 04-18-2022
By Business Wire 10-20-2021
By Business Wire 11-10-2021
Other Sources
By Yahoo Finance 2022-07-07
By Seekingalpha 2022-08-08
By Yahoo Finance 2022-10-20
By Yahoo Finance 2022-10-13
By tipranks.com 2022-08-08
By Yahoo Finance 2022-11-07
By Yahoo Finance 2022-06-21
By Yahoo Finance 2022-10-24
By Seekingalpha 2022-08-14
By Yahoo Finance 2022-03-24
By Yahoo Finance 2022-07-27
By tipranks.com 2022-11-07
By Yahoo Finance 2022-11-10
By Yahoo Finance 2022-05-09
By tipranks.com 2022-12-06
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.